Vericel manufactures advanced cell therapies for the sports medicine and severe burn care markets. The goal of our therapies is to repair or restore a patient’s damaged tissues or organs using their own cells. Please use the links to the right to visit our product websites.

NASDAQ: VCEL

$17.99 -0.1 (0%)
Day High: $18.4575
Day Low: $17.7761
Volume: 364288
4:00 PM on
September 24, 2020
Copyright West LLC. Minimum 15 minutes delayed.

Company Presentation